Accès gratuit
Numéro
Med Sci (Paris)
Volume 25, Numéro 12, Décembre 2009
Anticorps monoclonaux en thérapeutique
Page(s) 1149 - 1154
Section III - Un futur en développement
DOI https://doi.org/10.1051/medsci/200925121149
Publié en ligne 15 décembre 2009
  1. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256 : 495–7. [Google Scholar]
  2. Bruggemann M, Caskey HM, Teale C, et al. A repertoire of monoclonal antibodies with human heavy chains from transgenic mice. Proc Natl Acad Sci USA 1989; 86 : 6709–13. [Google Scholar]
  3. Lonberg N, Taylor LD, Harding FA, et al. Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature 1994; 368 : 856–9. [Google Scholar]
  4. Green LL, Hardy MC, Maynard-Currie CE, et al. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YAC. Nat Genet 1994; 7 : 13–21. [Google Scholar]
  5. Taylor LD, Carmack CE, Huszar D, et al. Human immunoglobulin transgenes undergo rearrangement, somatic mutation and class switching in mice that lack endogenous IgM. Int Immunol 1994; 6 : 579–91. [Google Scholar]
  6. Adderson EE, Shackelford PG, Insel RA, et al. Immunoglobulin light chain variable region gene sequences for human antibodies to Haemophilus influenzae type b capsular polysaccharide are dominated by a limited number of V kappa and V lambda segments and VJ combinations. J Clin Invest 1992; 89 : 729–38. [Google Scholar]
  7. Mendez MJ, Green LL, Corvalan JR, et al. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet 1997; 15 : 146–56. [Google Scholar]
  8. Green LL, Jakobovits A. Regulation of B cell development by variable gene complexity in mice reconstituted with human immunoglobulin yeast artificial chromosomes. J Exp Med 1998; 188 : 483–95. [Google Scholar]
  9. Tomizuka K, Shinohara T, Yoshida H, et al. Double trans-chromosomic mice : maintenance of two individual human chromosome fragments containing Ig heavy and kappa loci and expression of fully human antibodies. Proc Natl Acad Sci USA 2000; 97 : 722–7. [Google Scholar]
  10. Kuroiwa Y, Tomizuka K, Shinohara T, et al. Manipulation of human minichromosomes to carry greater than megabase-sized chromosome inserts. Nat Biotechnol 2000; 18 : 1086–90. [Google Scholar]
  11. Popov AV, Zou X, Xian J, Nicholson IC, Bruggemann M. A human immunoglobulin lambda locus is similarly well expressed in mice and humans. J Exp Med 1999; 189 : 1611–20. [Google Scholar]
  12. Nicholson IC, Zou X, Popov AV, et al. Antibody repertoires of four- and five-feature translocus mice carrying human immunoglobulin heavy chain and kappa and lambda light chain yeast artificial chromosomes. J Immunol 1999; 163 : 6898–906. [Google Scholar]
  13. Zou YR, Muller W, Gu H, Rajewsky K. Cre-loxP-mediated gene replacement : a mouse strain producing humanized antibodies. Curr Biol 1994; 4 : 1099–103. [Google Scholar]
  14. Harding FA, Lonberg N. Class switching in human immunoglobulin transgenic mice. Ann NY Acad Sci 1995; 764 : 536–46. [Google Scholar]
  15. Ball WJ, Jr., Kasturi R, Dey P, et al. Isolation and characterization of human monoclonal antibodies to digoxin. J Immunol 1999; 163 : 2291–8. [Google Scholar]
  16. Mukherjee J, Chios K, Fishwild D, et al. Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157 : H7 infection. Infect Immun 2002; 70 : 612–9. [Google Scholar]
  17. He Y, Honnen WJ, Krachmarov CP, et al. Efficient isolation of novel human monoclonal antibodies with neutralizing activity against HIV-1 from transgenic mice expressing human Ig loci. J Immunol 2002; 169 : 595–605. [Google Scholar]
  18. Chang Q, Zhong Z, Lees A, et al. Structure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin Loci. Infect Immun 2002; 70 : 4977–86. [Google Scholar]
  19. Villadsen LS, Schuurman J, Beurskens F, et al. Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J Clin Invest 2003; 112 : 1571–80. [Google Scholar]
  20. Bekker PJ, Holloway DL, Rasmussen AS, et al. A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J Bone Miner Res 2004; 19 : 1059–66. [Google Scholar]
  21. Yang XD, Corvalan JR, Wang P, et al. Fully human anti-interleukin-8 monoclonal antibodies : potential therapeutics for the treatment of inflammatory disease states. J Leukoc Biol 1999; 66 : 401–10. [Google Scholar]
  22. Teeling JL, French RR, Cragg MS, et al. Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas. Blood 2004; 104 : 1793–800. [Google Scholar]
  23. Schuler W, Bigaud M, Brinkmann V, et al. Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation. Transplantation 2004; 77 : 717–26. [Google Scholar]
  24. Bleeker WK, Lammerts van Bueren JJ, van Ojik HH, et al. Dual mode of action of a human anti-epidermal growth factor receptor monoclonal antibody for cancer therapy. J Immunol 2004; 173 : 4699–707. [Google Scholar]
  25. Imakiire T, Kuroki M, Shibaguchi H, et al. Generation, immunologic characterization and antitumor effects of human monoclonal antibodies for carcinoembryonic antigen. Int J Cancer 2004; 108 : 564–70. [Google Scholar]
  26. Foon KA, Yang XD, Weiner LM, et al. Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody. Int J Radiat Oncol Biol Phys 2004; 58 : 984–90. [Google Scholar]
  27. Skov L, Kragballe K, Zachariae C, et al. HuMax-CD4 : a fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris. Arch Dermatol 2003; 139 : 1433–9. [Google Scholar]
  28. Keler T, Halk E, Vitale L, et al. Activity and safety of CTLA-4 blockade combined with vaccines in cynomolgus macaques. J Immunol 2003; 171 : 6251–9. [Google Scholar]
  29. Phan GQ, Yang JC, Sherry RM, et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci USA 2003; 100 : 8372–7. [Google Scholar]
  30. Hermeling S, Crommelin DJ, Schellekens H, Jiskoot W. Structure-immunogenicity relationships of therapeutic proteins. Pharm Res 2004; 21 : 897–903. [Google Scholar]
  31. Mannon PJ, Fuss IJ, Mayer L, et al. Anti-interleukin-12 antibody for active Crohn’s disease. N Engl J Med 2004; 351 : 2069–79. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.